Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.

CMUR > College of Medicine > Graduate Institute of Cancer Biology > Journal articles > Item 310903500/41611

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/41611

Title:	Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.
Authors:	(Song, H.);(Li, C-W.);(LaBaff, A. M.);(Lim, S-O.);李龍緣(Long-Yuan Li);(Kan, S-F.);(Chen, Y.);(Zhang, K.);(Lang, J-Y.);(Xie, X.);(Wang, Y.);(Huo, L-F.);(Hsu, S-C.);(Chen, X-M.);(Zhao, Y-M.);洪明奇(Mien-Chie Hung)*
Contributors:	醫學院癌症生物學研究所;中國附醫院長室
Keywords:	EGFR;CBP;acetylation, SAHA
Date:	2011-01
Issue Date:	2011-10-21 10:36:32 (UTC+8)
Relation:	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 404(1):68-73
Appears in Collections:	[Graduate Institute of Cancer Biology] Journal articles

Files in This Item:

File	Description	Size	Format
20110330174450.pdf		573Kb	Adobe PDF	766	View/Open